For the Inventor, By the Inventor

Enter assignee name

San Diego, CA, United States of America

Ardea Biosciences, Inc

USPTO Granted Patents = 63

% Expired Patents = 60.3

CIPO Patents = 12

EPO Patents = 23

Forward Citations = 495

Loading Chart...

Loading Chart...

43 inventors (with patents filed for the assignee):

Jean-Luc Girardet (30 out of 35 patents)

Zhi Hong (21 out of 39 patents)

Jean-Michel Andre Vernier (20 out of 56 patents)

4. Esmir Gunic (19 out of 23 patents)

5. Yung-Hyo Koh (14 out of 17 patents)

6. Barry D Quart (12 out of 19 patents)

7. Andreas Maderna (9 out of 23 patents)

8. Stanley Lang (9 out of 10 patents)

9. Martha Alicia De La Rosa (8 out of 24 patents)

10. Samedy Ouk (7 out of 23 patents)

11. Li-Tain Yeh (7 out of 7 patents)

12. Stuart Dimock (6 out of 7 patents)

13. David A Paisner (5 out of 12 patents)

14. Jeffrey Miner (5 out of 5 patents)

15. Dinesh Barawkar (5 out of 5 patents)

Core Competencies:

CXCR-2 Inhibitors

Thioacetate Compounds

MEK Inhibitors

HIV Reverse Transcriptase

Pyridine Compounds

Polymorphic Forms

Uric Acid Modulation

Cancer Treatments

Pharmaceutical Compositions

Sulfonamides

Dihydropyridin Compounds

Purines

63 patents: Sort by Forward Citations

1. 10919858 - Thioacetate compounds, compositions and methods of use (2021-02-16),

2. 10772886 - CXCR-2 inhibitors for treating crystal arthropathy disorders (2020-09-15),

3. 10570095 - 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same (2020-02-25),

4. 10266493 - Thioacetate compounds, compositions and methods of use (2019-04-23),

5. 10183012 - Compounds and compositions and methods of use (2019-01-22),

6. 10047050 - 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same (2018-08-14),

7. 9956205 - Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and uses thereof (2018-05-01),

8. 9402827 - Treatment of gout (2016-08-02),

9. 9296709 - Manufacture of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid (2016-03-29),

10. 9296686 - Preparation of (R)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and (S)-N-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide (2016-03-29),

11. 9220696 - Pharmaceutical combinations for treatment of specific cancers (2015-12-29),

12. 9216179 - Treatment of gout and hyperuricemia (2015-12-22),

13. 9212135 - Phenylthioacetate compounds, compositions and methods of use (2015-12-15),

14. 9174933 - Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof (2015-11-03),

15. 9095581 - Combinations of MEK inhibitors and Raf kinase inhibitors and uses thereof (2015-08-04),

Ardea Biosciences, Inc., based in San Diego, CA, specializes in the development of pharmaceutical compounds with a focus on innovative therapies for cancer and other serious diseases. The company is recognized for its expertise in areas such as CXCR-2 inhibitors, MEK inhibitors, and HIV reverse transcriptase, contributing to advancements in treatment modalities. Ardea's research also encompasses thioacetate and pyridine compounds, as well as polymorphic forms aimed at modulating uric acid levels, showcasing its commitment to addressing complex medical challenges.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Ardea Biosciences, Inc

63 Patents

#99 in San Diego, CA

#1,343 in California

#5,753 in US

#11,611 in the World

San Diego, CA, United States of America

Ardea Biosciences, Inc

Forward Citations = 495

43 inventors:

Jean-Luc Girardet (30 out of 35 patents)

Zhi Hong (21 out of 39 patents)

Jean-Michel Andre Vernier (20 out of 56 patents)

4. Esmir Gunic (19 out of 23 patents)

5. Yung-Hyo Koh (14 out of 17 patents)

Please report any incorrect information to [email protected]

Loading…